MONISTAT® provides the broadest treatment of vaginal yeast infections,* more than Diflucan® (fluconazole) or any other prescription azole. Recent data also show that miconazole, the active ingredient in MONISTAT®, treats C. glabrata—the most prevalent non-albicans species—while the prescription azoles do not.16,18,22

Get exclusive savings for your patients.

MONISTAT®: Broadest treatment vs prescription azoles

Recommend MONISTAT® to cure your patients’ yeast infections


Finding the best treatment plan for your patients has never been more convenient. The Vulvovaginal Candidiasis app from the International Society for the Study of Vulvovaginal Disease (ISSVD) has been designed to be used during patient visits and includes such features as:

  • a treatment-by-species algorithm
  • wet-mount and clinical images
  • diagnosis and treatment information, including dosing

The ISSVD app is available at the App Store.

*vs all first-line prescription drug products

Diflucan is a registered trademark of Pfizer Inc.